CUSIP 75382E208COM NEWRAPTQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
101 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Tcg Crossover Management, LLC | 2.58M | $87.47M | +946.1K | Added |
| 2 | Fcpm III Services B.V. | 1.83M | $62.09M | +1.49M | Added |
| 3 | Orbimed Advisors LLC | 1.64M | $55.64M | +556.3K | Added |
| 4 | Rtw Investments, LP | 1.64M | $55.45M |
| +166.7K |
| Added |
| 5 | Foresite Capital Management Vi LLC | 1.56M | $52.92M | 0 | Held |
| 6 | Siren, L.L.C. | 1.38M | $46.57M | +794.5K | Added |
| 7 | Vanguard Group Inc | 1.19M | $40.20M | +490.6K | Added |
| 8 | Frazier Life Sciences Management, L.P. | 983.3K | $33.31M | +983.3K | New |
| 9 | Braidwell LP | 929.7K | $31.49M | +929.7K | New |
| 10 | Redmile Group, LLC | 885.9K | $30.01M | +333.3K | Added |
See every fund holding Rapt Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders